Posted in | News | Gold

Atacama Pacific Gold Reports Additional Results from Cerro Maricunga Gold Project in Chile

Atacama Pacific Gold has announced additional drilling results from the ongoing Phase III drill campaign at its Cerro Maricunga Gold Project, which is situated 140 km northeast of Copiapo, Chile. Highlights of the drill assay include 1.02 g/t gold over 144 m from the Crux Zone, including 34 m at 2.11 g/t gold; and 0.74 g/t gold over 278 m from the Lynx Zone, including 46 m at 1.29 g/t gold.

The Preliminary Phase III drilling program is primarily concentrated on boosting the size of the Crux Zone. This zone represents the gold mineralization’s southern centre along the 2.5 km northwest drifting Cerro Maricunga oxide gold deposit. During the Phase II drill campaign, the Crux Zone was not completely delineated. At the Crux Zone, the company has identified a core zone of gold mineralization of higher grade, measuring 300x200 m and expanding to depth. The drill hole CMD-104 intersected this higher grade zone, following up on prior results from CMD-001 and CMR-098 drill holes.

The ongoing drilling program at the Crux Zone, besides delineating a higher grade core zone, has shoved the zone’s northeast contact to an additional 100 m in excess of 450 m. The mineralization is exposed to depth and partly exposed to the northeast.

At the Phoenix Zone’s southern end, the CMR-110 drill hole intersected a wide zone of low-grade mineralization, which is 116 m grading 0.36 g/t gold beginning from surface, followed by additional zones of 0.2 to 0.3 g/t gold down hole and 50 m grading 0.26 g/t gold. This intercept signifies a new low-grade gold zone parallel and adjacent to the core mineralized trend.

Atacama Pacific’s President and CEO, Carl Hansen stated that drilling is progressing well with more than 27,000 m from the planned 42,000-m Phase III program concluded so far. In addition, the engineering scoping study is progressing well and a late second quarter delivery date is expected.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Atacama Pacific Gold Reports Additional Results from Cerro Maricunga Gold Project in Chile. AZoMining. Retrieved on November 23, 2024 from https://www.azomining.com/News.aspx?newsID=6101.

  • MLA

    Scanlon, Joel. "Atacama Pacific Gold Reports Additional Results from Cerro Maricunga Gold Project in Chile". AZoMining. 23 November 2024. <https://www.azomining.com/News.aspx?newsID=6101>.

  • Chicago

    Scanlon, Joel. "Atacama Pacific Gold Reports Additional Results from Cerro Maricunga Gold Project in Chile". AZoMining. https://www.azomining.com/News.aspx?newsID=6101. (accessed November 23, 2024).

  • Harvard

    Scanlon, Joel. 2019. Atacama Pacific Gold Reports Additional Results from Cerro Maricunga Gold Project in Chile. AZoMining, viewed 23 November 2024, https://www.azomining.com/News.aspx?newsID=6101.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.